AAAAAA

   
Results: 1-7 |
Results: 7
SERUM ALPHA-1-ACID GLYCOPROTEIN (AAG) IS AN INDEPENDENT PROGNOSTIC FACTOR FOR EFFICACY AND SURVIVAL IN PATIENTS WITH INOPERABLE NON-SMALL-CELL LUNG-CANCER (NSCLC) TREATED WITH TAXOTERE(R)
Authors: LECHEVALIER T BERILLE J OLIVARES R BRUNO R HAMMERSHAIMB L BIZZARI JP
Citation: T. Lechevalier et al., SERUM ALPHA-1-ACID GLYCOPROTEIN (AAG) IS AN INDEPENDENT PROGNOSTIC FACTOR FOR EFFICACY AND SURVIVAL IN PATIENTS WITH INOPERABLE NON-SMALL-CELL LUNG-CANCER (NSCLC) TREATED WITH TAXOTERE(R), Annals of oncology, 9, 1998, pp. 414-414
A PHASE-I AND PHARMACOKINETIC (PK) STUDY OF DOCETAXEL IN CANCER-PATIENTS WITH LIVER DYSFUNCTION DUE TO MALIGNANCIES
Authors: BAKER SD RAVDIN P AYLESWORTH C SMETZER L BRUNO R VERNILLET L PAZDUR R DOYLE G HAMMERSHAIMB L HOOKER E BURRIS HA ECKHARDT SG JOHNSON T KRAYNAK M HAMMOND L RODRIGUEZ G WEISS G ROWINSKY EK
Citation: Sd. Baker et al., A PHASE-I AND PHARMACOKINETIC (PK) STUDY OF DOCETAXEL IN CANCER-PATIENTS WITH LIVER DYSFUNCTION DUE TO MALIGNANCIES, Annals of oncology, 9, 1998, pp. 388-388
EFFICACY AND SAFETY OF SULESOMAB (LEUKOSCAN(R)) IN THE DIAGNOSIS OF ACUTE NONCLASSIC APPENDICITIS
Authors: BARRON B LAMKI L HANNA C PASSALAQUA A WEGENER W PINSKY CM HAMMERSHAIMB L MARKS DH GOLDENBERG DM
Citation: B. Barron et al., EFFICACY AND SAFETY OF SULESOMAB (LEUKOSCAN(R)) IN THE DIAGNOSIS OF ACUTE NONCLASSIC APPENDICITIS, The Journal of nuclear medicine, 38(5), 1997, pp. 85-85
I-131 LL2 (ANTI-CD22) RADIOIMMUNOTHERAPY (RIT) OF REFRACTORY NON-HODGKINS-LYMPHOMA (NHL) - RESULTS OF A REPETITIVE DOSING TRIAL
Authors: VOSE J COLCHER D BIERMAN P LEICHNER P AKABANI G HARRISON K HOHENSTEIN M LESSER S HAMMERSHAIMB L GOLDENBERG DM TEMPERO M ARMITAGE J
Citation: J. Vose et al., I-131 LL2 (ANTI-CD22) RADIOIMMUNOTHERAPY (RIT) OF REFRACTORY NON-HODGKINS-LYMPHOMA (NHL) - RESULTS OF A REPETITIVE DOSING TRIAL, The Journal of nuclear medicine, 38(5), 1997, pp. 211-211
USE OF CARCINOEMBRYONIC ANTIGEN RADIOIMMUNODETECTION AND COMPUTED-TOMOGRAPHY FOR PREDICTING THE RESECTABILITY OF RECURRENT COLORECTAL-CANCER
Authors: HUGHES K PINSKY CM PETRELLI NJ MOFFAT FL PATT YZ HAMMERSHAIMB L GOLDENBERG DM
Citation: K. Hughes et al., USE OF CARCINOEMBRYONIC ANTIGEN RADIOIMMUNODETECTION AND COMPUTED-TOMOGRAPHY FOR PREDICTING THE RESECTABILITY OF RECURRENT COLORECTAL-CANCER, Annals of surgery, 226(5), 1997, pp. 621-631
CLINICAL UTILITY OF EXTERNAL IMMUNOSCINTIGRAPHY WITH THE IMMU-4 TC-99M FAB' ANTIBODY FRAGMENT IN PATIENTS UNDERGOING SURGERY FOR CARCINOMA OF THE COLON AND RECTUM - RESULTS OF A PIVOTAL, PHASE-III TRIAL
Authors: MOFFAT FL PINSKY CM HAMMERSHAIMB L PETRELLI NJ PATT YZ WHALEY FS GOLDENBERG DM
Citation: Fl. Moffat et al., CLINICAL UTILITY OF EXTERNAL IMMUNOSCINTIGRAPHY WITH THE IMMU-4 TC-99M FAB' ANTIBODY FRAGMENT IN PATIENTS UNDERGOING SURGERY FOR CARCINOMA OF THE COLON AND RECTUM - RESULTS OF A PIVOTAL, PHASE-III TRIAL, Journal of clinical oncology, 14(8), 1996, pp. 2295-2305
THERAPY OF REFRACTORY NON-HODGKINS-LYMPHOMA (NHL) WITH I-131 LL2 (ANTI-CD22) RADIOIMMUNOTHERAPY (RIT) - RESULTS OF A REPETITIVE DOSING TRIAL
Authors: VOSE J COLCHER D BIERMAN P LEICHNER P AKABANI G HARRISON K HOHENSTEIN M LESSER S HAMMERSHAIMB L GOLDENBERG DM TEMPERO M ARMITAGE J
Citation: J. Vose et al., THERAPY OF REFRACTORY NON-HODGKINS-LYMPHOMA (NHL) WITH I-131 LL2 (ANTI-CD22) RADIOIMMUNOTHERAPY (RIT) - RESULTS OF A REPETITIVE DOSING TRIAL, Blood, 88(10), 1996, pp. 2258-2258
Risultati: 1-7 |